LeMaitre Vascular market cap is $523.6 m.

LeMaitre Vascular Gross profit (Q2, 2019)20.3 M

LeMaitre Vascular Gross profit margin (Q2, 2019), %68.9%

LeMaitre Vascular Net income (Q2, 2019)4.6 M

LeMaitre Vascular EBIT (Q2, 2019)5.9 M

LeMaitre Vascular Cash, 30-Jun-201913.3 M

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Revenue | 64.5m | 71.1m | 78.4m | 89.2m | 100.9m | |

| 10% | 10% | 14% | |||

## Cost of goods sold | 19.4m | 22.7m | 24.2m | 26.2m | 30.2m | 31.6m |

## Gross profit | 45.1m | 48.4m | 54.2m | 62.9m | 70.7m | |

| 70% | 68% | 69% | 71% | 70% | |

## Sales and marketing expense | 22.1m | 22.8m | 26.1m | 25.9m | 27.3m | |

## R&D expense | 5.2m | 5.5m | 6.1m | 6.6m | 8.2m | |

## General and administrative expense | 12.6m | 14.0m | 14.4m | 17.0m | 17.7m | |

## Operating expense total | 40.6m | 42.7m | 46.6m | 49.6m | 45.7m | |

## EBIT | 4.5m | 6.3m | 11.5m | 16.3m | 21.1m | 28.2m |

| 7% | 9% | 15% | 18% | 21% | |

## Interest expense | 12.0k | 5.0k | 14.0k | 21.0k | 2.0k | |

## Interest income | 4.0k | 1.0k | 13.0k | 81.0k | 179.0k | 631.0k |

## Pre tax profit | 4.3m | 6.3m | 11.4m | 16.2m | 21.1m | 28.4m |

## Income tax expense | 1.1m | 2.4m | 3.7m | 5.7m | 3.9m | 5.5m |

## Net Income | 3.2m | 3.9m | 7.8m | 10.6m | 17.2m | 22.9m |

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Cash | 14.7m | 18.7m | 27.5m | 24.3m | 19.1m | 26.3m |

## Accounts Receivable | 243.9m | |||||

## Inventories | 13.3m | 2.4m | 15.2m | 2.0m | ||

## Current Assets | 41.7m | 48.6m | 58.2m | 59.0m | 80.3m | 94.0m |

## PP&E | 5.8m | 6.9m | 7.0m | 8.0m | 12.4m | 14.1m |

## Goodwill | 15.0m | 17.3m | 17.8m | 23.4m | 23.8m | 29.9m |

## Total Assets | 70.5m | 81.5m | 90.7m | 101.9m | 126.3m | 153.1m |

## Accounts Payable | 1.2m | 1.1m | 1.4m | 1.2m | 1.5m | 1.7m |

## Short-term debt | ||||||

## Current Liabilities | 10.2m | 10.0m | 10.4m | 10.5m | 13.2m | 19.8m |

## Long-term debt | ||||||

## Total Debt | ||||||

## Total Liabilities | 13.9m | 12.8m | 14.4m | 16.6m | 22.9m | |

## Additional Paid-in Capital | 65.4m | 75.4m | 82.1m | 85.4m | 93.1m | 98.4m |

## Retained Earnings | (667.0k) | 3.2m | 8.2m | 15.3m | 28.3m | 45.8m |

## Total Equity | 56.6m | 68.2m | 77.9m | 87.5m | 109.8m | 130.2m |

## Financial Leverage | 1.2 x | 1.2 x | 1.2 x | 1.2 x | 1.2 x | 1.2 x |

USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
---|---|---|---|---|---|---|

## Net Income | 3.2m | 3.9m | 7.8m | 10.6m | 17.2m | 22.9m |

## Depreciation and Amortization | 2.8m | 3.3m | 3.4m | 3.6m | 4.1m | 4.3m |

## Accounts Receivable | (1.2m) | (654.0k) | (1.9m) | (922.0k) | (1.5m) | (1.3m) |

## Inventories | (2.2m) | (2.7m) | 608.0k | |||

## Accounts Payable | 861.0k | (1.1m) | 2.6m | (103.0k) | 1.5m | 4.3m |

## Cash From Operating Activities | 5.4m | 5.5m | 11.4m | 16.9m | 22.9m | 19.5m |

## Purchases of PP&E | (2.7m) | (1.2m) | (2.3m) | (2.8m) | (6.4m) | (3.1m) |

## Cash From Investing Activities | (6.2m) | (7.7m) | (3.5m) | (17.2m) | (29.0m) | (7.1m) |

## Long-term Borrowings | (1.1m) | (1.1m) | (1.1m) | |||

## Cash From Financing Activities | (961.0k) | 6.7m | 1.1m | (2.6m) | 80.0k | (4.4m) |

USD | Y, 2019 |
---|---|

## Financial Leverage | 1.2 x |